In September 2015, Salford CCG commissioned Haelo to run a Breakthrough Series (BTS) Collaborative with eight GP practices focusing on improving the prescribing, monitoring and reconciliation of a discrete group of high risk medications, specifically Non-Steroidal Anti Inflammatory Drugs (NSAIDS), Methotrexate and Amiodarone.
The eight practices included:
- Clarendon Medical Practice
- Langworthy Medical Centre
- Blackfriars Medical Practice
- Mosslands Medical Practice
- Pendleton Medical Centre
- Salford Health Matters
- St Andrews Medical Practice 2
- St Andrews Medical Practice 3
Based on the PINCER audit tool , Haelo along with the innovation team at Salford CCG and the expert faculty developed a suite of measures, a shared measurement strategy and data collection processes for the collaborative to answer the question “how do we know that change is an improvement?”
Aim: 95% of patients on high risk medicines (NSAIDS, Methotrexate and Amiodarone) will have optimised medicines care by October 2016.
The below driver diagram was developed for the programme and articulates the collaborative theory for change and how the collaborative practices will achieve the aim